Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.

News | AHA

HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions

October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the ...

October 04, 2022

The stage is set for the American Heart Association (AHA) Scientific Sessions 2022, to be held November 5-7 at McCormick Place in Chicago, and virtually.

News | AHA

AHA Scientific Sessions 2022 Program, Late-breakers Announced

October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick ...

October 04, 2022

The World Connect Theater at TCT 2022 hosted dozens of panel discussions joining global cardiovascular specialists sharing scientific breakthroughs to large and attentive audiences throughout the Sept. 16-20 event in Boston, MA.

Feature | TCT | By Christine Book

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review

The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research ...

October 03, 2022

The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: Most-read Content in September

Here is a recap of what DAIC viewers found most interesting during the month of September:

1. Unloading with Impella ...

October 03, 2022

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and one of the world's foremost educational forum specializing in interventional cardiovascular medicine, is marking its 34th year in 2022, from September 16-19 in Boston, returning to its pre-pandemic format.

Gallery | TCT | By Melinda Taschetta-Millane and Christine Book

Photo Gallery Highlighting TCT 2022

The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics ( ...

October 03, 2022

The multi-center first-in-men study evaluates the safety and performance of the next generation of BIOTRONIK’s Resorbable Magnesium Scaffold (RMS)

News | Stents Bioresorbable

BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold

September 28, 2022 — In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...

September 28, 2022

Magmaris Scaffold Performs Well in Real World Settings Even in More Complex Patient Groups

News | Stents Bioresorbable

BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

September 27, 2022 — BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...

September 27, 2022

Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.

News | Heart Valve Technology

Edwards Launches Sapien 3 Ultra Resilia Valve Following FDA Approval

September 26, 2022 — Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates ...

September 26, 2022

Study of the Paradise Ultrasound Renal Denervation System Shows Significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension

News | Hypertension

ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

September 26, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the ...

September 26, 2022

Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with cardiogenic shock due to myocarditis.

News | Cardiogenic Shock

Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%

September 22, 2022 — Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella ...

September 22, 2022

David J. Cohen, MD, MSc, St. Francis Hospital and CRF, presented Jennifer A. Rymer, MD, Duke University Medical Center with the TCT 2022 Thomas J. Linnemeier Young Investigator Award, along with co-presenter Gary S. Mintz of the Cardiovascular Research Foundation (CRF) on Sept 19 in Boston, MA.

News | TCT

TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award

September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young ...

September 22, 2022

Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7 mmHg in ambulatory pulse pressure after 6 months of therapy in control patients who crossed over to BackBeat CNT following completion of the randomized portion of the MODERATO II study

News | Hypertension

Orchestra BioMed Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT at TCT 2022

September 20, 2022 — Orchestra BioMed, Inc., a biomedical innovation company accelerating high-impact technologies to ...

September 20, 2022

Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventions

News | Structural Heart

Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery

September 20, 2022 — Results of the first randomized controlled trial to directly compare two contemporary transcatheter ...

September 20, 2022

Results from TVT registry analysis presented at TCT and published simultaneously in the Journal of the American College of Cardiology

News | Cardiogenic Shock

STS/ACC TVT Registry Analysis Assesses Use of Transcatheter Edge-to-Edge Repair in Severe Mitral Regurgitation and Cardiogenic Shock

September 20, 2022 — An analysis from the Society of Thoracic Surgeons/American College of Cardiology(STS/ACC) TVT ...

September 20, 2022

The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).

News | TCT

TCT 2022 Announces Winner of Shark Tank Innovation Award

September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as ...

September 20, 2022